Higher-than-expected claims underline the need for tailored coverage and expanded facultative capacity to help safeguard the critical semiconductor supply chain.
New policy addresses management liability needs unique to life sciences, biotech, and pharmaceutical firms and is specifically designed for the R&D ecosystem.